Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2013
11/20/2013CN103396471A Metal beta-lactamase inhibitory peptide and application thereof
11/20/2013CN103396427A Synthesis of boronic ester and acid compound
11/20/2013CN102757478B Allyl cysteinyl amino acid derivative and synthesis method and application thereof
11/20/2013CN102329246B Multiple-target-point tamibarotene derivatives, preparation method and purposes thereof
11/20/2013CN102174077B Oligopeptide molecules with intramolecular disulfide bonds and application thereof to assisting in protein oxidation renaturation
11/20/2013CN101528921B Translocation and mutant ros kinase in human non-small cell lung carcinoma
11/19/2013US8586707 Stapled peptides and method of synthesis
11/19/2013US8586570 Sox-based kinase sensor
11/19/2013US8586541 Polymeric biosurfactants
11/19/2013CA2528375C Macrocyclic antagonists of the motilin receptor
11/19/2013CA2473987C Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
11/14/2013WO2003006605A9 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/14/2013US20130303447 Methods for preventing or treating insulin resistance
11/14/2013US20130303435 Smart Pro-Drugs of Serine Protease Inhibitors
11/14/2013US20130302357 Novel benzodiazepine derivatives
11/13/2013CN103387602A Novel open-chain tetrapeptide analogue and preparation method and use thereof
11/13/2013CN103387601A Anti-dengue virus (DENV) heterocyclic peptide compounds and preparing methods and uses thereof
11/13/2013CN103387600A New preparation method of L-alanyl-L-glutamine
11/13/2013CN102241741B Prion protein ligands and methods of use
11/13/2013CN102159587B Pseudoproline dipeptides
11/13/2013CN102105553B Novel lipid dipeptide and gel
11/12/2013US8580923 Self-assembling peptide amphiphiles and related methods for growth factor delivery
11/12/2013US8580920 Peptides useful for skin lightening
11/12/2013US8580918 Peptidic GLP-2 agonists
11/12/2013US8580557 Casein hydrolyzate, process for producing the same and use thereof
11/12/2013US8580493 Screening for compounds that modulate GPR3-mediated beta-arrestin signaling and amyloid beta peptide generation
11/12/2013US8580297 Components for producing amphoteric liposomes
11/12/2013CA2609811C Angiotensin i - converting enzyme (ace) inhibitors
11/12/2013CA2587310C Tripeptide and tetrapeptide sulfones
11/07/2013WO2013165262A1 Peptides, constructs and uses therefor
11/07/2013WO2013132317A8 Peptidomimetic compounds as immunomodulators
11/07/2013US20130296245 Prolinamiade derivatives as thrombin inhibitor, prepraration method and application thereof
11/06/2013EP2658859A2 Macrocyclic hepatitis c serine protease inhibitors
11/06/2013CN103382216A Cyanoisoquinoline compounds and methods of use thereof
11/06/2013CN102787154B Preparation method of black-bone chicken oligopeptide and separation and identification method of active peptide fragment
11/06/2013CN102766193B Colorectal cancer specific antigen peptide and colorectal cancer detection kit
11/06/2013CN102643639B Force-induced fluorescence discolor materials with property of multiple colors change and preparation method and application thereof
11/06/2013CN102066402B Peptide derivative and composition for promoting tear secretion comprising the same
11/06/2013CN102038932B Metal-binding compounds and uses therefor
11/06/2013CN101982458B 3-amino-3-arylpropionic acid and preparation method thereof
11/06/2013CN101467039B Disheveled pdz modulators
11/06/2013CN101273042B Macrocyclic inhibitors of hepatitis C virus
11/05/2013US8575307 Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
10/2013
10/31/2013WO2013124701A3 Homo- and heterodimeric smac mimetic compounds as apoptosis inducers
10/31/2013WO2002077001A9 Novel receptors
10/31/2013WO2002064559A3 Thrombin inhibitors
10/31/2013US20130289240 Cyclin Based Inhibitors of CDK2 and CDK4
10/30/2013EP2656854A1 Uses of aromatic-cationic peptide
10/30/2013EP2655399A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
10/30/2013EP2655398A2 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quinazoline trisodium salt
10/30/2013EP2655386A1 Process for preparing platinum-carbene complexes
10/30/2013EP2655385A1 Novel platinum-carbene complexes and use thereof as medicaments
10/30/2013CN103374057A New compound with inhibiting activity to glycine transporters
10/30/2013CN103374056A 1-Acetyl-beta-carboline-3-formyl amino-acid benzyl ester, and synthesis and application thereof
10/30/2013CN103374055A Method for separating and purifying reduced glutathione (GSH) from reduced glutathione contained fermentation leaching liquid
10/30/2013CN101611050B Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
10/29/2013US8569258 Low density lipoprotein receptor-mediated siRNA delivery
10/29/2013US8569234 Compositions and methods for including melanogenesis in a subject
10/29/2013US8569230 Antimicrobial kinocidin compositions and methods of use
10/29/2013US8569005 Chloroacetamidine based inhibitors and activity based probes for the protein arginine methytransferases
10/29/2013US8568781 Peptide-carrying nanoparticles
10/29/2013CA2731177C Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors
10/29/2013CA2662876C Michael systems as transglutaminase inhibitors
10/29/2013CA2558615C Azabicyclo-octane inhibitors of iap
10/29/2013CA2469134C Novel peptide and pharmaceutical use of the same
10/29/2013CA2434643C Peptides for activation and inhibition of.delta.pkc
10/24/2013WO2013158600A1 Multivalent peptoid oligomers, pharmaceutical compositions and methods of using same
10/24/2013WO2013156493A1 Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
10/24/2013WO2013155595A1 Process for the preparation of a monosodium salt of h-d-glu-(l-trp-oh)-oh and a crystalline form thereof
10/24/2013WO2013155592A1 Crystal forms of golotimod and process for its manufacturing
10/24/2013WO2012140500A9 Selective cysteine protease inhibitors and uses thereof
10/24/2013US20130281660 Detection of degradative anzymes and biomolecules in bodily fluids
10/24/2013US20130281657 Macrocycles and macrocycle stabilized peptides
10/24/2013US20130281385 Small molecule apoptosis promoters
10/24/2013US20130281358 Peptide
10/24/2013US20130280760 High purity lipopetides
10/23/2013EP2366704B1 Inhibitors of serine proteases
10/23/2013CN103370331A Amino statin derivatives for the treatment of arthrosis
10/23/2013CN103370089A Material for tissue regeneration, aqueous protein solution containing same, and method for gelling same
10/23/2013CN103360463A Separation and purification method of dalfopristin and intermediate thereof
10/23/2013CN103360462A Refining method of alanyl-glutamine crude drug
10/23/2013CN103360348A Carfilzomib intermediate and preparation method thereof, and preparation method of Carfilzomib
10/23/2013CN102807607B Fused ring heterocycle compound for restraining hepatitis c virus, midbody and application of fused ring heterocycle compound
10/23/2013CN102492021B Preparation process for bortezomib
10/22/2013US8563686 Conformationally constrained peptide mimetics
10/22/2013US8563684 Tumor antigen protein SART-3 and tumor antigen peptides thereof
10/22/2013US8563515 Tight junction protein modulators and uses thereof
10/22/2013US8563514 Peptides and pharmaceutical compositions for treating connective tissue
10/22/2013US8563273 Method of screening for compounds that disaggregate amyloid aggregates
10/22/2013CA2699891C Macrocyclic compounds as antiviral agents
10/22/2013CA2491594C Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
10/17/2013WO2013154208A1 Method for identifying and quantifying types of animal hair
10/17/2013WO2013152688A1 Separation and purification method for dalfopristin and intermediate thereof
10/17/2013US20130274439 Antiviral compounds
10/17/2013US20130274208 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
10/17/2013US20130274206 Compositions and Methods for Promoting Wound Healing and Tissue Regeneration
10/17/2013US20130273090 Antigen-norovirus p-domain monomers and dimers, antigen norovirus p-particle molecules, and methods for their making and use
10/16/2013EP2648735A2 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
10/16/2013CN102675416B Beta-carboline derivatives, and preparation method and application thereof
10/15/2013US8557961 Alpha 1-antitrypsin compositions and methods of making and using same
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 307